Acetyl-d-carnitine is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with Acetyl-d-carnitine
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Proteostasis Deficiencies | D057165 | 5 associated lipids |
| Parkinson Disease | D010300 | 53 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Cleft Lip | D002971 | 8 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Amino Acid Metabolism, Inborn Errors | D000592 | 16 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Patel SP et al. | Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. | 2012 | Neuroscience | pmid:22445934 |
| Ren J et al. | Dynamic monitoring of carnitine and acetylcarnitine in the trimethylamine signal after exercise in human skeletal muscle by 7T 1H-MRS. | 2013 | Magn Reson Med | pmid:22473634 |
| Wadman RI et al. | Drug treatment for spinal muscular atrophy types II and III. | 2012 | Cochrane Database Syst Rev | pmid:22513940 |
| pmid:22533417 | ||||
| pmid:22549035 | ||||
| Muoio DM et al. | Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. | 2012 | Cell Metab. | pmid:22560225 |
| Sharma S et al. | Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I. | 2012 | Free Radic. Biol. Med. | pmid:22583703 |
| pmid:22592719 | ||||
| pmid:2262440 | ||||
| Smeland OB et al. | Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice. | 2012 | Neurochem. Int. | pmid:22709675 |
| Morand R et al. | Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans. | 2012 | Ther Drug Monit | pmid:22743351 |
| pmid:22753396 | ||||
| Karalija A et al. | Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats. | 2012 | PLoS ONE | pmid:22815926 |
| Hu S et al. | Use of hyperpolarized [1-13C]pyruvate and [2-13C]pyruvate to probe the effects of the anticancer agent dichloroacetate on mitochondrial metabolism in vivo in the normal rat. | 2012 | Magn Reson Imaging | pmid:22819176 |
| Ang JE et al. | Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach. | 2012 | Chronobiol. Int. | pmid:22823870 |
| Muralidharan AR et al. | Deciphering the potential efficacy of acetyl-L-carnitine (ALCAR) in maintaining connexin-mediated lenticular homeostasis. | 2012 | Mol. Vis. | pmid:22876134 |
| pmid:2289524 | ||||
| pmid:22947198 | ||||
| Mallinson JE et al. | Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. | 2012 | J. Physiol. (Lond.) | pmid:23045346 |
| pmid:2306109 | ||||
| Kanazirska MV et al. | Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells. | 2012 | Curr Pharm Biotechnol | pmid:23072393 |
| pmid:23081917 | ||||
| pmid:231113 | ||||
| pmid:23214468 | ||||
| Schaevitz LR et al. | Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome. | 2012 | PLoS ONE | pmid:23227269 |
| pmid:2323071 | ||||
| Sahlin K | Muscle carnitine metabolism during incremental dynamic exercise in humans. | 1990 | Acta Physiol. Scand. | pmid:2327259 |
| pmid:23278446 | ||||
| Siliprandi N et al. | Metabolic changes induced by maximal exercise in human subjects following L-carnitine administration. | 1990 | Biochim. Biophys. Acta | pmid:2328258 |
| pmid:23296212 | ||||
| Federighi G et al. | Differentially expressed genes in Hirudo medicinalis ganglia after acetyl-L-carnitine treatment. | 2013 | PLoS ONE | pmid:23308261 |
| Nasca C et al. | L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. | 2013 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23382250 |
| pmid:23386399 | ||||
| pmid:23389620 | ||||
| pmid:2339783 | ||||
| Zuena AR et al. | Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine. | 2013 | PLoS ONE | pmid:23409035 |
| pmid:23411015 | ||||
| Mazzocchio R et al. | Enhancement of recurrent inhibition by intravenous administration of L-acetylcarnitine in spastic patients. | 1990 | J. Neurol. Neurosurg. Psychiatry | pmid:2341845 |
| pmid:23421600 | ||||
| pmid:23428336 | ||||
| Lodi A et al. | Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease. | 2013 | PLoS ONE | pmid:23431376 |
| pmid:2344045 | ||||
| Russo SJ and Charney DS | Next generation antidepressants. | 2013 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23471996 |
| Hanada H et al. | Acetyl-L-carnitine suppresses thyroid hormone-induced and spontaneous anuran tadpole tail shortening. | 2013 | Hereditas | pmid:23489246 |
| pmid:23545238 | ||||
| Ryckman KK et al. | The influence of maternal disease on metabolites measured as part of newborn screening. | 2013 | J. Matern. Fetal. Neonatal. Med. | pmid:23550828 |
| pmid:23625722 | ||||
| Schloss JM et al. | Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review. | 2013 | Clin Nutr | pmid:23647723 |
| Wu SN et al. | [Analysis of propionylcarnitine in blood and methylmalonic acid in urine of 162 patients with methylmalonic acidemia]. | 2013 | Zhonghua Yi Xue Za Zhi | pmid:23663331 |
| Cuccurazzu B et al. | Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine. | 2013 | Neuropsychopharmacology | pmid:23670591 |